Back to search

Article

Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides strong protection against virulent parasites

2022-07-26

Abstract excerpt

<title>Abstract</title> <p>The poor abilities of parasitic antigens to induce cell-mediated immunity is one of the major reasons for the limited success of vaccine candidates against all forms of leishmaniasis. Here we find, for the first time, that the adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies significantly enhances CD4+ T cells mediated immunity in vaccinated an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e6d7c9bc-15dd-5cc0-81b5-cf9b9be789d4
DOI
10.21203/rs.3.rs-1817941/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides strong protection against virulent parasitesDOI 10.21203/rs.3.rs-1817941/v1
Select a neighboring publication to make it the new centre.